These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 6250364)

  • 41. Peripheral resistance to the cellular action of insulin in obese diabetic subjects in vivo.
    Reckless JP; Galton DJ
    Clin Sci (Lond); 1980 Jan; 58(1):59-63. PubMed ID: 6243525
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Catecholamine-induced cAMP response in streptozotocin-induced diabetic rat liver.
    Yamatani K; Marubashi S; Wakasugi K; Saito K; Sato N; Takahashi K; Sasaki H
    Tohoku J Exp Med; 1994 Jul; 173(3):311-20. PubMed ID: 7846683
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Participation of the liver and epididymal adipose tissue in the obesity of one-year-old obese New Zealand mice (NZO)].
    Winand J; Furnelle J; Georis M; Christophe J
    Bull Soc Chim Biol (Paris); 1968; 50(11):2069-81. PubMed ID: 5716416
    [No Abstract]   [Full Text] [Related]  

  • 44. Selective phosphodiesterase inhibition and alterations of cardiac function by alkylated xanthines.
    Mushlin P; Boerth RC; Wells JN
    Mol Pharmacol; 1981 Jul; 20(1):179-89. PubMed ID: 6270531
    [No Abstract]   [Full Text] [Related]  

  • 45. Characterization of an in vivo hormonally regulated phosphodiesterase 3 (PDE3) associated with a liver Golgi-endosomal fraction.
    Geoffroy V; Fouque F; Lugnier C; Desbuquois B; Benelli C
    Arch Biochem Biophys; 2001 Mar; 387(1):154-62. PubMed ID: 11368177
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Attenuation of epinephrine-induced increase in liver cyclic AMP by endogeneous insulin in vivo.
    Shikama H; Ui M
    Biochim Biophys Acta; 1976 Sep; 444(2):461-71. PubMed ID: 183827
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical studies and applications of cyclic nucleotides.
    Murad F
    Adv Cyclic Nucleotide Res; 1973; 3():355-83. PubMed ID: 4357645
    [No Abstract]   [Full Text] [Related]  

  • 48. Hormonal regulation of lipolysis: role of cyclic nucleotides, adenosine, and free fatty acids.
    Fain JN; Shepherd RE
    Adv Exp Med Biol; 1979; 111():43-77. PubMed ID: 218431
    [No Abstract]   [Full Text] [Related]  

  • 49. Modulation of gluconeogenesis by epinephrine in hepatocytes isolated from genetically obese (fa/fa) Zucker rats.
    Sánchez-Gutiérrez JC; Sánchez-Arias JA; Samper B; Felíu JE
    Arch Biochem Biophys; 2000 Jan; 373(1):249-54. PubMed ID: 10620345
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of hyperthermic stress on blood glucagon levels in normal and diabetic rats.
    Kampa IS; Frascella DW; Hundertmark JM; Rosenberg JM; Reid V
    Horm Metab Res; 1981 Feb; 13(2):122. PubMed ID: 6262204
    [No Abstract]   [Full Text] [Related]  

  • 51. [Glucagon, 2d pancreatic hormone].
    Lefebvre M
    Diabete; 1968; 16(3):232-7. PubMed ID: 5760505
    [No Abstract]   [Full Text] [Related]  

  • 52. Measurement of both cyclic [3H]AMP and cyclic [3H]GMP in cultured vascular smooth muscle cells labeled with [3H]hypoxanthine: use in studies of cardiovascular drugs.
    Maurice DH; Lee RM; Haslam RJ
    Anal Biochem; 1993 Nov; 215(1):110-7. PubMed ID: 8297002
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The influence of obesity and diabetes in the monkey on insulin and glucagon binding to liver membranes.
    Lockwood DH; Hamilton CL; Livingston JN
    Endocrinology; 1979 Jan; 104(1):76-81. PubMed ID: 221171
    [No Abstract]   [Full Text] [Related]  

  • 54. Cyclic AMP, cyclic GMP and glucose utilization by diabetic rat fat cells.
    Chiappe de Cingolani GE
    Arch Int Physiol Biochim; 1983 Apr; 91(1):1-8. PubMed ID: 6192778
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cyclic nucleotides in pathophysiology.
    Hamet P; Tremblay J; Pang SC
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():651-9. PubMed ID: 6328945
    [No Abstract]   [Full Text] [Related]  

  • 56. Guanine-nucleotide-binding proteins in diabetes and insulin-resistant states.
    Bushfield M; Griffiths SL; Strassheim D; Tang E; Shakur Y; Lavan B; Houslay MD
    Biochem Soc Symp; 1990; 56():137-54. PubMed ID: 2124120
    [No Abstract]   [Full Text] [Related]  

  • 57. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1.
    Yoon JC; Puigserver P; Chen G; Donovan J; Wu Z; Rhee J; Adelmant G; Stafford J; Kahn CR; Granner DK; Newgard CB; Spiegelman BM
    Nature; 2001 Sep; 413(6852):131-8. PubMed ID: 11557972
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of adipose S-100 protein release by insulin.
    Suzuki F; Kato K
    Biochim Biophys Acta; 1985 May; 845(2):311-6. PubMed ID: 2986724
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cyclic GMP binding protein of rat heart and urinary cyclic nucleotides in patients with diabetes mellitus before and after treatment.
    Takahashi K; Takai T; Seino Y; Takao H; Imura H
    Kobe J Med Sci; 1978 Dec; 24(4):177-92. PubMed ID: 216849
    [No Abstract]   [Full Text] [Related]  

  • 60. Somatostatin inhibits urinary cyclic AMP excretion in diabetic rats.
    Hertelendy F; Calabria D; Todd H; Raab B
    Endocrinology; 1977 Oct; 101(4):1095-8. PubMed ID: 198195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.